Your session is about to expire
← Back to Search
Online Education + Webinars for Palliative Care (CAPACITI Trial)
N/A
Waitlist Available
Led By Hsien Seow, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one month post module
Awards & highlights
CAPACITI Trial Summary
This trial will assess whether the CAPACITI intervention can increase competency among primary care teams to deliver early palliative care.
CAPACITI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one month post module
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one month post module
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assignment Completion & Change Survey
End-of-Life Professional Caregiver Survey (EPCS)
Proportion of case load identified as requiring a palliative care approach
Secondary outcome measures
Assessment of Interprofessional Team Collaboration Scale II (AITCS II)
CAPACITI Competencies Survey
Module Session Evaluation
CAPACITI Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment2 Interventions
Access to all the CAPACITI module materials, provided on a learning management system. The intervention group will also receive the CAPACITI program with module facilitation, namely high-facilitation and expert coaching in the coverage of module materials in four live webinars (bimonthly for the 2 month duration of the module = 4 webinars).
Group II: ControlActive Control1 Intervention
Access to all the CAPACITI module materials, provided on a learning management system. The control group will not receive module facilitation (i.e., will entail self-directed learning).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Facilitated online webinars
2021
N/A
~570
Find a Location
Who is running the clinical trial?
McMaster UniversityLead Sponsor
884 Previous Clinical Trials
2,597,750 Total Patients Enrolled
3 Trials studying Palliative Care
833 Patients Enrolled for Palliative Care
Hsien Seow, PhDPrincipal InvestigatorDepartment of Oncology, McMaster University and Juravinski Cancer Centre
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The healthcare team must be part of the local community and ready to provide care to relieve symptoms, address emotional needs, teach patients and families, and work together with other healthcare providers.You do not wish to receive comfort care.You do not live in the community where the study is taking place.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experimental program available to recruits at the present time?
"According to information on clinicaltrials.gov, the trial that was initially posted in October 5th 2021 is no longer seeking participants at this moment. However, there are 44 other trials actively recruiting patients presently."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger